<code id='DF7AC5F151'></code><style id='DF7AC5F151'></style>
    • <acronym id='DF7AC5F151'></acronym>
      <center id='DF7AC5F151'><center id='DF7AC5F151'><tfoot id='DF7AC5F151'></tfoot></center><abbr id='DF7AC5F151'><dir id='DF7AC5F151'><tfoot id='DF7AC5F151'></tfoot><noframes id='DF7AC5F151'>

    • <optgroup id='DF7AC5F151'><strike id='DF7AC5F151'><sup id='DF7AC5F151'></sup></strike><code id='DF7AC5F151'></code></optgroup>
        1. <b id='DF7AC5F151'><label id='DF7AC5F151'><select id='DF7AC5F151'><dt id='DF7AC5F151'><span id='DF7AC5F151'></span></dt></select></label></b><u id='DF7AC5F151'></u>
          <i id='DF7AC5F151'><strike id='DF7AC5F151'><tt id='DF7AC5F151'><pre id='DF7AC5F151'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:8241
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Roivant's CEO is a star, but biotech's black hole persists
          Roivant's CEO is a star, but biotech's black hole persists

          MollyFerguson/STATRoivantSciences’MattGlinemightbethisyear’sbestbiopharmaCEO,andotherthoughtsaboutMo

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

          BiogenCEOChristopherViehbacherSTATTwoyearsafterabigscientificswingnearlypushedBiogentothebrink,CEOCh